← All trials
NCT05890495
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2023
- Primary completion
- Dec 31, 2023
- Completion date
- Jan 31, 2024
- First posted
- Jun 6, 2023
- Last posted
- Jun 6, 2023
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Uniformed Services University of the Health SciencesLead sponsor
- American Academy of Family PhysiciansCollaborator
- Uniformed Services University of the Health SciencesReponsible party - principal investigator
- Uniformed Services University of the Health SciencesOfficial
- Uniformed Services University of the Health SciencesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.